Correlation Between GlaxoSmithKline PLC and Coeur DAlene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Coeur DAlene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Coeur DAlene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Coeur dAlene Bancorp, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Coeur DAlene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Coeur DAlene. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Coeur DAlene.

Diversification Opportunities for GlaxoSmithKline PLC and Coeur DAlene

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between GlaxoSmithKline and Coeur is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Coeur dAlene Bancorp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coeur dAlene Bancorp and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Coeur DAlene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coeur dAlene Bancorp has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Coeur DAlene go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Coeur DAlene

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 7.16 times less return on investment than Coeur DAlene. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 1.18 times less risky than Coeur DAlene. It trades about 0.01 of its potential returns per unit of risk. Coeur dAlene Bancorp is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  1,088  in Coeur dAlene Bancorp on August 26, 2024 and sell it today you would earn a total of  587.00  from holding Coeur dAlene Bancorp or generate 53.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy85.51%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Coeur dAlene Bancorp

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Coeur dAlene Bancorp 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Coeur dAlene Bancorp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Coeur DAlene may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and Coeur DAlene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Coeur DAlene

The main advantage of trading using opposite GlaxoSmithKline PLC and Coeur DAlene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Coeur DAlene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coeur DAlene will offset losses from the drop in Coeur DAlene's long position.
The idea behind GlaxoSmithKline PLC ADR and Coeur dAlene Bancorp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bonds Directory
Find actively traded corporate debentures issued by US companies
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency